Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Not Yet Recruiting

Rutgers University Study of the Genetics of Blood Cancers

NCT07714044

Conditions: Blood Cancer, Blood Cancers, Hematologic Cancer, +17 more
Locations: Rutgers University Piscataway, New Jersey, United States

View Trial Details

Not Yet Recruiting

A Phase II Study to Evaluate the Efficacy of UF-KURE19 Cells in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

NCT07713459

Conditions: CAR T Cell Therapy, Diffuse Large B Cell Lymphoma (DLBCL), Follicular B-cell Non-Hodgkin's Lymphoma, +14 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study of Topical Duvelisib in Participants With Early-stage Mycosis Fungoides

NCT07714187

Conditions: Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Not Yet Recruiting

Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype

NCT07341867

Conditions: Blood Protein Disorders, Breast Diseases, Breast Neoplasms, +21 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Not Yet Recruiting

Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy

NCT07711327

Conditions: Arrhythmias, Cardiac, Atrial Fibrillation, Atrial Fibrillation (AF), +35 more
Locations: City of Hope Duarte, California, United States

UC San Diego Health San Diego, California, United States

Stanford Health Care Stanford, California, United States

View Trial Details

Not Yet Recruiting

GLORY: Glofit-GemOx With Liso-Cel For Lymphoma

NCT07711483

Conditions: B-Cell Lymphomas, Disease Attributes, Hemic and Lymphatic Diseases, +14 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Not Yet Recruiting

Pre-emptive Anakinra for Cytokine Event Reduction

NCT06703216

Conditions: B-Acute Lymphoblastic Leukemia, Burkitt Lymphoma, CAR-T Cell Therapy, +24 more
Locations: Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States

View Trial Details

Not Yet Recruiting

New Genotype-guided Treatment in Newly Diagnosed PTCL

NCT07706959

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Ruijin Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

A Clinical Trial of MK-1045 in People With B-cell Cancer (MK-1045-006)

NCT07709000

Conditions: Chronic Disease, Chronic Lymphocytic Leukaemia, Disease Attributes, +18 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Phase 2 Trial of CD70.CAR NK Cells for Patients With Primary Refractory or Early Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma

NCT07164469

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +8 more
Locations: The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions